Delivery Order SPE2DB24D1205-SPE2DB25FCXZM
- Not listed
- The Defense Logistics Agency awarded a $23,960.38 delivery order to AmerisourceBergen Drug Corp for ENBREL 50 MG/ML SureClick auto-injector pens, with an ultimate completion date of August 21, 2025. This non-competitive, firm fixed-price delivery order was issued on August 20, 2025, and will be fulfilled from the vendor's corporate office location in Conshohocken, Pennsylvania. The award represents a child contract action under AmerisourceBergen's larger Indefinite Delivery Contract with DLA...
- The Defense Logistics Agency awarded a $39,057.22 delivery order to AmerisourceBergen Drug Corp for ENBREL 50 mg/ml SureClick auto-injectors, with an ultimate completion date of July 7, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and represents a child order under AmerisourceBergen's broader pharmaceutical supply agreement with DLA. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate...
- The Defense Logistics Agency awarded a delivery order valued at $10,226.52 to AmerisourceBergen Drug Corp for the supply of Enbrel 50 mg/mL SureClick auto-injector pens. This firm fixed-price delivery order was competitively awarded without set-aside designation and is scheduled for completion by July 21, 2025. The product will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania, where the company maintains its corporate headquarters and pharmaceutical distribution...
- The Defense Logistics Agency awarded a $62,114.93 delivery order to AmerisourceBergen Drug Corp for ENBREL 50 mg/mL SureClick auto-injectors, with an ultimate completion date of May 20, 2025. This competitively awarded, firm fixed-price contract represents a child delivery order under AmerisourceBergen's larger pharmaceutical supply vehicle with DLA. The product will be performed at the contractor's facility in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate office...
- The Defense Logistics Agency awarded a $32,259.65 firm fixed price delivery order to AmerisourceBergen Drug Corp for ENBREL 50 mg/ml SureClick auto-injector pens, with an ultimate completion date of July 29, 2025. This non-set-aside contract represents a competitive award to support federal medical supply requirements. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor and critical vendor for military and veteran healthcare systems,...
- The Defense Logistics Agency awarded a delivery order valued at $14,927.95 to AmerisourceBergen Drug Corp for Enbrel 50 mg/mL SureClick auto-injector pens, with performance in Conshohocken, Pennsylvania and completion scheduled for August 5, 2025. This firm fixed-price delivery order was competitively awarded without any set-aside designation, reflecting AmerisourceBergen's established capability to meet federal pharmaceutical procurement requirements through open competition. This delivery...
- The Defense Logistics Agency awarded a $14,002.71 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Enbrel 50 mg/ml SureClick auto-injector pens, with an ultimate completion date of August 8, 2025. This non-set-aside award was issued on August 8, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp is a major pharmaceutical distributor and critical federal medical supply vendor that serves military...
- The Defense Logistics Agency awarded a $54,357.69 firm fixed price delivery order to AmerisourceBergen Drug Corp on September 8, 2025, for Enbrel 50 mg/mL SureClick auto-injector pens. This non-set-aside contract is a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The product will be performed at AmerisourceBergen's corporate headquarters location in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order valued at approximately $37,038 to AmerisourceBergen Drug Corp on September 4, 2025, for the supply of Enbrel 50 mg/ml SureClick auto-injector pens. This is a firm fixed price, competitively awarded contract with no set-aside designation, with ultimate completion scheduled for September 5, 2025. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a...
- The Defense Logistics Agency awarded a delivery order valued at $10,181.76 to AmerisourceBergen Drug Corp for ENBREL 50 mg/mL SureClick auto-injector pens, with performance in Conshohocken, Pennsylvania. This non-set-aside, competitively awarded contract operates under a firm fixed price structure with a completion date of June 17, 2025. The delivery order represents a single transactional draw from AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical...
- SPE2DB24D1205Indefinite Delivery Contract
- SPE2DB24D1205-SPE2DB25FCXZMDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $15,467.93 to AmerisourceBergen Drug Corp for ENBREL 50 MG/ML SureClick auto-injector pens, with an ultimate completion date of June 25, 2025. This firm fixed price delivery order represents a non-set-aside competitive award and will be performed at the company's corporate office location in Conshohocken, Pennsylvania. The award is issued as a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a comprehensive $999,999,999.00 global pharmaceutical supply vehicle running through December 2026. AmerisourceBergen Drug Corp serves as a critical pharmaceutical distributor for federal medical procurement, supplying the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems with brand-name medications, generic drugs, vaccines, and specialized medical devices. ENBREL, a biologic immunosuppressant used primarily to treat rheumatoid arthritis and other autoimmune conditions, is a specialty pharmaceutical product consistent with the company's portfolio of complex medications supporting military healthcare programs. This delivery order exemplifies the routine pharmaceutical supply transactions executed under the company's prime DLA contract, which enables flexible procurement of medical commodities to support military personnel worldwide.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $15.5k | 6/24/25 |